Stay updated on PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial
Sign up to get notified when there's something new on the PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial page.

Latest updates to the PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial page
- CheckyesterdayChange DetectedAdded a Show glossary option and updated footer metadata to display 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedUpdated site revision from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check36 days agoChange DetectedAdded Revision: v3.3.3; removed the HHS Vulnerability Disclosure link and Revision: v3.3.2 from the footer.SummaryDifference0.1%

- Check65 days agoChange DetectedStudy status updated to Completed with an actual completion date of 2025-09-22, and Last Update Posted and Revision metadata were added (Last Update Posted 2025-11-14; Revision: v3.3.2). A note in Publications indicates PubMed-sourced entries are auto-filled and may not all be about the study.SummaryDifference0.5%

- Check72 days agoChange DetectedRemoved a general funding-status notice that does not affect trial details, eligibility, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check87 days agoChange DetectedExpanded and updated the list of trial sites on the Study Details page, listing numerous French locations. This provides current enrollment options and contact points for potential participants.SummaryDifference0.3%

Stay in the know with updates to PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial page.